Human behaviour, cost-effectiveness analysis and research and development priorities: The case of a schistosomiasis vaccine

Tropical Medicine and International Health

Volumn 2, Issue 11, 1997, Pages

  Evans, D B ^a   Guyatt, H L ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cost effectiveness analysis; Culture and behaviour; Schistosomiasis vaccine

Indexed keywords

COST EFFECTIVENESS; DECISION MAKING; HEALTH PLANNING; RESEARCH AND DEVELOPMENT; SCHISTOSOMIASIS; VACCINATION;

CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HUMAN; INFECTION CONTROL; SCHISTOSOMIASIS; VACCINATION;

COST-BENEFIT ANALYSIS; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; RESEARCH; SCHISTOSOMIASIS; TREATMENT OUTCOME; VACCINES;

EID: 0030665844     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)